Patents by Inventor Karsten HÄFFNER

Karsten HÄFFNER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polypeptides for inhibiting complement activation
    Patent number: 11591378
    Abstract: The invention relates to a polypeptide comprising a C3 convertase effector domain, a C5 convertase effector domain and optionally a terminal complex inhibitory effector domain which is resistant to deregulation by physiologic FHR-Proteins and has a dimerization motif, and to its therapeutic use.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: February 28, 2023
    Assignee: ELEVA GMBH
    Inventors: Stefan Michelfelder, Karsten Häffner
  • POLYPEPTIDES FOR INHIBITING COMPLEMENT ACTIVATION
    Publication number: 20200277347
    Abstract: The invention relates to a polypeptide comprising a C3 convertase effector domain, a C5 convertase effector domain and optionally a terminal complex inhibitory effector domain which is resistant to deregulation by physiologic FHR-Proteins and has a dimerization motif, and to its therapeutic use.
    Type: Application
    Filed: March 20, 2020
    Publication date: September 3, 2020
    Applicant: GREENOVATION BIOTECH GMBH
    Inventors: Stefan MICHELFELDER, Karsten HÄFFNER
  • Polypeptides for inhibiting complement activation
    Patent number: 10640540
    Abstract: The invention relates to a polypeptide comprising a C3 convertase effector domain, a C5 convertase effector domain and optionally a terminal complex inhibitory effector domain which is resistant to deregulation by physiologic FHR-Proteins and has a dimerization motif, and to its therapeutic use.
    Type: Grant
    Filed: December 23, 2016
    Date of Patent: May 5, 2020
    Assignee: GREENOVATION BIOTECH GMBH
    Inventors: Stefan Michelfelder, Karsten Häffner
  • POLYPEPTIDES FOR INHIBITING COMPLEMENT ACTIVATION
    Publication number: 20190300589
    Abstract: The invention relates to a polypeptide comprising a C3 convertase effector domain, a C5 convertase effector domain and optionally a terminal complex inhibitory effector domain which is resistant to deregulation by physiologic FHR-Proteins and has a dimerization motif, and to its therapeutic use.
    Type: Application
    Filed: December 23, 2016
    Publication date: October 3, 2019
    Applicant: GREENOVATION BIOTECH GMBH
    Inventors: Stefan MICHELFELDER, Karsten HÄFFNER
  • Furniture for aircraft
    Patent number: D830712
    Type: Grant
    Filed: March 3, 2017
    Date of Patent: October 16, 2018
    Assignee: Qatar Airways Q.C.S.C.
    Inventors: Nigel Anthony Goode, Benjamin Michael Rowan, Christopher James Haslam, Felix Karsten Haeffner, Elizabeth Kyle Scorgie
  • Furniture for aircraft
    Patent number: D850131
    Type: Grant
    Filed: March 3, 2017
    Date of Patent: June 4, 2019
    Assignee: Qatar Airways Q.C.S.C.
    Inventors: Nigel Anthony Goode, Benjamin Michael Rowan, Christopher James Haslam, Felix Karsten Haeffner, Elizabeth Kyle Scorgie
  • Furniture for aircraft
    Patent number: D850132
    Type: Grant
    Filed: September 21, 2018
    Date of Patent: June 4, 2019
    Assignee: Qatar Airways Q.C.S.C.
    Inventors: Nigel Anthony Goode, Benjamin Michael Rowan, Christopher James Haslam, Felix Karsten Haeffner, Elizabeth Kyle Scorgie